Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Development of a nationwide genomic screening network for lung cancer with rare driver oncogenes and investigation of the mechanism of drug resistance

Date

08 Oct 2016

Session

Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Presenters

Shingo Matsumoto

Authors

S. Matsumoto

Author affiliations

Department Of Thoracic Oncology, National Cancer Center Hospital East, 277-8577 - Kashiwa/JP

More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

08 Oct 2016

Treatment decisions at ALK TKI resistance

Presenter: Maurice Perol

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast

08 Oct 2016

Introduction

Presenter: Yuichiro Ohe

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast

08 Oct 2016

Conclusions and clinical perspectives

Presenter: Solange Peters

Session: Joint Symposium ESMO-JSMO: How to overcome resistance of target therapy for lung cancer

Resources:

Presentation

Webcast